treatment patterns

Videos

Treatment Patterns After PD1/L1 Inhibitor Discontinuation in Advanced Urothelial Carcinoma

03/18/2021

Journal of Clinical Pathways

Videos

Real-World Treatment Sequences After First-Line Therapy in Metastatic RCC

03/18/2021

Journal of Clinical Pathways

Videos

Real-World Treatment Patterns, FLT3 Testing, and Outcomes in AML

01/14/2021

Amer Zeidan, MBBS, MHS, discusses results from a retrospective study examining FLT3 testing trends, treatment patterns, and overall survival in relapsed/refractory AML.

Amer Zeidan, MBBS, MHS,...

01/14/2021

Journal of Clinical Pathways

ENGAGING EXPERTS

Real-World Treatment Patterns, HCRU in Patients With CML Achieving Later Lines of Therapy

01/14/2021

Ehab Atallah, MD, discusses results from a study evaluating treatment patterns in patients with CML achieving later lines of therapy, and estimating the associated HCRU and costs.

Ehab Atallah, MD, discusses...

01/14/2021

Journal of Clinical Pathways

Conference Coverage

Real-World Treatment Patterns, Health Care Resource Utilization, and Costs in CML

12/05/2020

For patients with CML, switching to the subsequent lines of therapy is frequent due to previous TKI intolerance and results in high medical costs.

For patients with CML, switching...

12/05/2020

Journal of Clinical Pathways

$Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States$

Research Reports

Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States

02/18/2020

Andrew J. Klink , PhD, MPH;

Anna G. Purdum , PharmD, MS;

Chadi Nabhan , MD, MBA, FACP;

Bruce A. Feinberg , DO;

Choo Hyung Lee , MS;

Yin Yang , MS;

JaLyna Laney , RN, OCN;

Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...

...

02/18/2020

Journal of Clinical Pathways